Early primary biliary cholangitis is characterised by brain abnormalities on cerebral magnetic resonance imaging by Grover, VPB, Southern, L, Dyson, JK, Kim, JU, Crossey, MME, Wylezinska-Arridge, M, Patel, N, Fitzpatrick, JA, Bak-Bol, A, Waldman, AD, Alexander, GJ, Mells, GF, Chapman, RW, Jones, DEJ, Taylor-Robinson, SD

Ursodeoxycholic acid and severe COVID-19 outcomes in a cohort study using the OpenSAFELY platform by Costello, RE, Waller, KMJ, Smith, R, Mells, GF, Wong, AYS, Schultze, A, Mahalingasivam, V, Herrett, E, Zheng, B, Lin, L, MacKenna, B, Mehrkar, A, Bacon, SCJ, Goldacre, B, Tomlinson, LA, Tazare, J, Rentsch, CT

Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System by Goode, EC, Clark, AB, Mells, GF, Srivastava, B, Spiess, K, Gelson, WTH, Trivedi, PJ, Lynch, KD, Castren, E, Vesterhus, MN, Karlsen, TH, Ji, S-G, Anderson, CA, Thorburn, D, Hudson, M, Heneghan, MA, Aldersley, MA, Bathgate, A, Sandford, RN, Alexander, GJ, Chapman, RW, Walmsley, M, Uk-PSC Consortium, Hirschfield, GM, Rushbrook, SM